Marco Anselmo

Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience

Matteo Bassetti, Nadia Castaldo, Anna Maria Cattelan et al. · International Journal of Antimicrobial Agents · 2018 · 161 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +8

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

Alessandro Grasso, Federica Malfatti, Pasqualina De Leo et al. · Journal of Hepatology · 2009 · 85 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)

Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe et al. · Open Forum Infectious Diseases · 2020 · 68 citations · Full text

Veterinary Medicine, Clinical Sciences, Infectious Diseases +17

Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy

Matteo Bassetti, Andrea Parisini, Anna Calzi et al. · Clinical Microbiology and Infection · 2010 · 31 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +10

Feasibility of UV–VIS–Fluorescence spectroscopy combined with pattern recognition techniques to authenticate a new category of plant food supplements

Raffaella Boggia, Federica Turrini, Marco Anselmo et al. · Journal of Food Science and Technology · 2017 · 20 citations · Full text

Agriculture, Food Science, Plant Sciences +16